This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: 7Tm Pharma A/s. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Pia Karina Noeregaard: Innovator in CB1 Receptor Modulation
Introduction
Pia Karina Noeregaard is a prominent inventor based in Hoersholm, Denmark. She has made significant contributions to the field of pharmacology, particularly in the development of compounds that modulate CB1 receptors. Her innovative work aims to address critical health issues such as obesity and related conditions.
Latest Patents
Pia Karina Noeregaard holds 2 patents related to her research on CB1 receptor modulators. Her latest patents include compounds of formula (I) that suppress the normal signaling activity of CB1 receptors. These compounds are designed to be useful in the treatment of diseases or conditions mediated by CB1 receptor signaling, including obesity and overweight. The compounds aim to prevent weight gain and treat conditions directly or indirectly associated with obesity.
Career Highlights
Pia is currently associated with 7tm Pharma A/S, where she continues her research and development efforts. Her work is pivotal in advancing therapeutic options for obesity and related health issues.
Collaborations
Pia has collaborated with notable professionals in her field, including Martin Cooper and Jean-Marie Receveur. These collaborations have further enriched her research and innovation efforts.
Conclusion
Pia Karina Noeregaard is a trailblazer in the field of CB1 receptor modulation, with a focus on combating obesity and its associated health challenges. Her contributions are vital to the ongoing development of effective treatments in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile